Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
GMED
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
zacks.com
9 hours ago
zacks.com
10 hours ago
zacks.com
13 hours ago
seekingalpha.com
15 hours ago
globenewswire.com
16 hours ago
zacks.com
20 hours ago
Earnings Growth
YoY
Current
Estimates
Q3.23
+14%
0.57
vs 0.5
Q4.23
+2%
0.6
vs 0.59
Q1.24
+36%
0.72
vs 0.53
Q2.24
+19%
0.75
vs 0.63
Q3.24
+46%
0.83
vs 0.57
Q4.24
+40%
0.84
vs 0.6
Q1.25
-6%
0.68
vs 0.72
Q2.25
+15%
0.86
vs 0.75
Q3.25
-6%
0.78
vs 0.83
Q4.25
+7%
0.9
vs 0.84
Sales Growth
YoY
Current
Estimates
Q3.23
+51%
383.6M vs 254.1M
Q4.23
+125%
616.5M vs 274.5M
Q1.24
+119%
606.7M vs 276.7M
Q2.24
+116%
629.7M vs 291.6M
Q3.24
+63%
625.7M vs 383.6M
Q4.24
+7%
657.3M vs 616.5M
Q1.25
-1%
598.1M vs 606.7M
Q2.25
+18%
745.3M vs 629.7M
Q3.25
+17%
734M vs 625.7M
Q4.25
+18%
777.8M vs 657.3M
Return on Equity
QoQ
Q1.23
+3%
0.03
vs 0.03
Q2.23
+3%
0.03
vs 0.03
Q3.23
+0%
0
vs 0.03
Q4.23
+0%
0
vs 0
Q1.24
0%
-0.00
vs 0
Q2.24
+1%
0.01
vs -0.00
Q3.24
+1%
0.01
vs 0.01
Q4.24
+1%
0.01
vs 0.01
Q1.25
+2%
0.02
vs 0.01
Q2.25
+5%
0.05
vs 0.02
Institutionnal Ownership
QoQ
Q1.23
402
402
vs 394
2%
Q2.23
390
390
vs 402
-3%
Q3.23
439
439
vs 390
13%
Q4.23
420
420
vs 439
-4%
Q1.24
450
450
vs 420
7%
Q2.24
456
456
vs 450
1%
Q3.24
458
458
vs 456
0%
Q4.24
511
511
vs 458
12%
Q1.25
519
519
vs 511
2%
Q2.25
478
478
vs 519
-8%
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
0.00(N/A)
Number of analyst
0
Last analyst upgrade/downgrade
BTIG
upgradePrevious: Not converted
2024-03-18
Now: Buy
Canaccord Genuity
upgradePrevious: Not converted
2023-03-30
Now: Buy
CFRA
upgradePrevious: Not converted
2023-02-09
Now: Hold
Quote Panel
Key Metrics
Relative Strength
GMED
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|